Bickel W K, Higgins S T, Hughes J R
Department of Psychiatry, University of Vermont College of Medicine, Burlington 05401.
J Exp Anal Behav. 1991 Sep;56(2):217-37. doi: 10.1901/jeab.1991.56-217.
Drugs often disrupt the acquisition of new response sequences at doses that fail to disrupt the performance of a previously acquired response sequence. This selective drug effect may result from differences in the control exerted by the stimuli presented after each response in the acquisition and performance sequences. To examine the function of these stimuli, an observing procedure was incorporated into a multiple schedule of repeated acquisition and performance of response sequences, in which stimulus presentations were contingent upon an observing response. Three experiments were conducted with humans. Experiment 1 compared responding with and without the observing contingency. No difference was found in the overall percentage of errors across the two conditions. Within the observing condition, observing behaviour was maintained in the acquisition component as long as errors occurred, but was not maintained in the performance component. Experiment 2 examined whether a contingency that increased errors also would increase observing in both the acquisition and performance components. Specifically, reinforcer delivery in each component was contingent upon emitting 10 correct responses and one, two, or four errors. Observing responses increased in the acquisition component as the error requirement increased, whereas observing responses in the performance component increased only when the error requirement was four. Experiment 3 assessed the effects of diazepam (0, 7.5, 15, and 30 mg/70 kg, p.o.) and triazolam (0, 0.375, and 0.75 mg/70 kg, p.o.) on repeated acquisition and performance baselines with the observing contingency. Selective drug effects were obtained in this modified procedure; that is, the percentage of errors in the acquisition component increased at doses that failed to affect the percentage of errors in the performance components. Importantly, drug effects were selective, even though observing responses were not emitted in the performance component and, hence, the stimulus presentations did not occur in that component. These findings suggest that alternative explanations for these differential effects are needed; in that regard, a response-unit account of the selective drug effects is discussed.
药物常常在未能干扰先前习得的反应序列表现的剂量下,干扰新反应序列的习得。这种选择性药物效应可能源于在习得和表现序列中每次反应后呈现的刺激所施加的控制差异。为了检验这些刺激的功能,将一种观察程序纳入到反应序列重复习得和表现的多重时间表中,其中刺激呈现取决于观察反应。对人类进行了三项实验。实验1比较了有和没有观察偶然性时的反应。在这两种条件下,错误的总体百分比没有差异。在观察条件下,只要出现错误,观察行为就在习得部分得以维持,但在表现部分则不能维持。实验2考察了增加错误的偶然性是否也会增加习得和表现部分的观察。具体而言,每个部分的强化物发放取决于发出10次正确反应以及1次、2次或4次错误。随着错误要求的增加,习得部分的观察反应增加,而表现部分的观察反应仅在错误要求为4次时增加。实验3评估了地西泮(0、7.5、15和30毫克/70千克,口服)和三唑仑(0、0.375和0.75毫克/70千克,口服)对带有观察偶然性的重复习得和表现基线的影响。在这个修改后的程序中获得了选择性药物效应;也就是说,习得部分的错误百分比在未能影响表现部分错误百分比的剂量下增加。重要的是,即使在表现部分没有发出观察反应,因此在该部分没有发生刺激呈现,药物效应也是选择性的。这些发现表明需要对这些差异效应进行其他解释;在这方面,讨论了选择性药物效应的反应单元解释。